Accedi a banche dati online | Convegnodetail
Anteprima di stampa
 
 

2nd Gene Therapy Immunogenicity

Evvnt Promotion / evvnt
-
03.08.2021 - 05.08.2021  Online
Time: 08:00 - 17:30
 
Temi della conferenza
The 2nd Gene Therapy Immunogenicity Summit is the industry's definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate.

In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and innovative biotechs to ensure that you're up to speed on the latest approaches to predict, measure
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Andrew Byrnes, Head Gene Transfer and Immunogenicity Branch, FDA, Klaudia Kuranda, Immunology Lead, Spark Therapeutics, David Markusic, Research Professor, IUPUI, Cathryn Clary, Acting Chief Medical Officer, Bridge Bio and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/754695-1?pid=4832
Ms. Ellie Saunders
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
Conference Only Ticket (First Release): $1599.0, Conference Only Ticket (Second Release): $1699.0, Conference Only Ticket (Third Release): $1899.0, Conference Only Ticket (Fourth Release): $1999.0, Conference Only Ticket (Final Price): $2099.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Alumni Club Medizinische Universität WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrzte der WeltSwiss Tropical and Public Health InstituteCharité International AcademyAMREF - African Medical and Research FoundationÖsterreichisches Rotes Kreuz